BR112012007550A2 - composição em gel, produtos de tratamento de verruga, e de calos/calosidade, método para tratar uma doença de pele, dispensador para administrar uma composição para tratar uma doença de pele em um indivíduo, e, método para aprimorar administração tópica de ácido salicílico a um indivíduo - Google Patents

composição em gel, produtos de tratamento de verruga, e de calos/calosidade, método para tratar uma doença de pele, dispensador para administrar uma composição para tratar uma doença de pele em um indivíduo, e, método para aprimorar administração tópica de ácido salicílico a um indivíduo

Info

Publication number
BR112012007550A2
BR112012007550A2 BR112012007550A BR112012007550A BR112012007550A2 BR 112012007550 A2 BR112012007550 A2 BR 112012007550A2 BR 112012007550 A BR112012007550 A BR 112012007550A BR 112012007550 A BR112012007550 A BR 112012007550A BR 112012007550 A2 BR112012007550 A2 BR 112012007550A2
Authority
BR
Brazil
Prior art keywords
treating
individual
skin disease
composition
salicylic acid
Prior art date
Application number
BR112012007550A
Other languages
English (en)
Other versions
BR112012007550A8 (pt
BR112012007550B1 (pt
Inventor
Eric Chen-Nan Su
Gerald R Dever
William Scott Rogers
Original Assignee
Msd Consumer Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msd Consumer Care Inc filed Critical Msd Consumer Care Inc
Publication of BR112012007550A2 publication Critical patent/BR112012007550A2/pt
Publication of BR112012007550A8 publication Critical patent/BR112012007550A8/pt
Publication of BR112012007550B1 publication Critical patent/BR112012007550B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

composição em gel, produtos de tratamento de verruga, e de calos/calosidade, método para tratar uma doença de pele, dispensador para administrar uma composição para tratar uma doença de pele em um indivíduo, e, método para aprimorar administração tópica de ácido salicílico a um indivíduo. uma composição em gel com baixo teor de éter para aplicação à pele que compreende um agente queratolítico, em particular ácido salicílico e que compreendendo uma nitrocelulose e um ou mais ingredientes voláteis, que forma um filme em contato com a pele adequado para formar uma barreira protetora para o agente queratolítico durante um período de tempo necessário para fornecer tratamento à pele; métodos para tratamento usando tais composição e dispensadores contendo tais composições.
BR112012007550A 2009-10-08 2010-10-04 composição em gel, produtos para tratamento de verruga, e de calos/calosidades, método para tratar uma doença de pele, dispensador para administrar uma composição para tratar uma doença de pele em um indivíduo, e, método para aprimorar administração tópica de ácido salicílico a um indivíduo. BR112012007550B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24978809P 2009-10-08 2009-10-08
PCT/US2010/051257 WO2011044008A1 (en) 2009-10-08 2010-10-04 Low ether composition and delivery apparatus

Publications (3)

Publication Number Publication Date
BR112012007550A2 true BR112012007550A2 (pt) 2016-12-06
BR112012007550A8 BR112012007550A8 (pt) 2018-06-12
BR112012007550B1 BR112012007550B1 (pt) 2020-01-14

Family

ID=43855046

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012007550A BR112012007550B1 (pt) 2009-10-08 2010-10-04 composição em gel, produtos para tratamento de verruga, e de calos/calosidades, método para tratar uma doença de pele, dispensador para administrar uma composição para tratar uma doença de pele em um indivíduo, e, método para aprimorar administração tópica de ácido salicílico a um indivíduo.

Country Status (16)

Country Link
US (1) US8883767B2 (pt)
EP (1) EP2485720B1 (pt)
JP (4) JP5798561B2 (pt)
KR (1) KR101791705B1 (pt)
CN (2) CN107411990A (pt)
AR (2) AR078553A1 (pt)
AU (1) AU2010303696B2 (pt)
BR (1) BR112012007550B1 (pt)
CA (1) CA2775089C (pt)
ES (1) ES2688976T3 (pt)
HK (1) HK1247133A1 (pt)
IN (1) IN2012DN02817A (pt)
MX (1) MX2012004144A (pt)
RU (1) RU2552470C2 (pt)
TW (1) TWI488628B (pt)
WO (1) WO2011044008A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2616030A1 (en) 2005-07-20 2007-01-25 Lab Partners Associates, Inc. Wireless photographic communication system and method
WO2008150902A1 (en) 2007-05-29 2008-12-11 Lab Partners Associates, Inc. System and method for maintaining hot shoe communications between a camera and a wireless device
JP6308137B2 (ja) * 2012-12-28 2018-04-11 大正製薬株式会社 皮膚適用製剤
JP2014234377A (ja) * 2013-06-04 2014-12-15 ニチバン株式会社 サリチル酸含有製剤、及び、その製造方法
MX2016002246A (es) * 2013-08-21 2017-04-27 Verrica Pharmaceuticals Inc Composiciones, métodos y sistemas para el tratamiento de trastornos cutáneos.
KR102528106B1 (ko) 2014-12-17 2023-05-03 베리카 파마슈티컬스 인크. 칸타리딘 및 생활성 칸타리딘 유도체의 상업적으로 실행 가능한 합성
WO2016118633A1 (en) 2015-01-20 2016-07-28 Verrica Pharmaceuticals, Inc. Quantification and preparation of pharmaceutical grade cantharidin
EP3258908A4 (en) 2015-02-20 2018-08-22 Pedicis Research LLC Compositions and methods for treatment of skin infections
ES2620319B1 (es) * 2015-12-28 2018-05-04 Laboratorios Viñas S.A. Composición farmacéutica para uso tópico de ácido salicílico para tratamiento de la hiperqueratosis y método correspondiente
JP6775976B2 (ja) * 2016-03-18 2020-10-28 小林製薬株式会社 皮膚摩擦軽減用外用製剤
ITUA20162327A1 (it) * 2016-04-05 2017-10-05 Sixtem Life Srl Prodotto per il trattamento di lesioni della pelle e di verruche e dispositivo applicatore
CA3065151A1 (en) 2017-06-06 2018-12-13 Verrica Pharmaceuticals Inc. Treatment of cutaneous disorders
USD900312S1 (en) 2017-06-15 2020-10-27 Verrica Pharmaceuticals, Inc. Applicator
CA3066079A1 (en) * 2017-06-15 2018-12-20 Verrica Pharmaceuticals Inc. Devices and methods for the treatment of body surface disorders
JP6968589B2 (ja) * 2017-06-26 2021-11-17 小林製薬株式会社 皮膜形成性外用製剤
JP7048221B2 (ja) * 2017-06-26 2022-04-05 小林製薬株式会社 皮膜形成性外用製剤
US10993950B2 (en) * 2017-08-04 2021-05-04 Poli Md S.R.L. Medical device for the treatment of HPV cutaneous infections
KR102648939B1 (ko) * 2023-08-18 2024-03-19 한국콜마주식회사 산을 고함량으로 함유하는 화장료 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4149814A (en) * 1977-06-20 1979-04-17 E. I. Du Pont De Nemours And Company Fountain brush liquid applicator
US4783185A (en) * 1986-07-07 1988-11-08 Minnesota Mining And Manufacturing Company Pen-like dispenser for applying rust converting liquid
JPH02311414A (ja) * 1989-05-29 1990-12-27 Shiseido Co Ltd 皮膚外用剤
US5433950A (en) 1990-05-07 1995-07-18 Schering-Plough Healthcare Products, Inc. Flexible collodion compositions
EP0569532A1 (en) * 1991-02-01 1993-11-18 Stiefel Laboratories, Inc. Improved flexible collodion compositions
JP3117502B2 (ja) * 1991-08-27 2000-12-18 株式会社資生堂 皮膚外用剤
RU2114607C1 (ru) * 1997-06-24 1998-07-10 Закрытое акционерное общество "Садко" Лечебно-гигиеническое и косметическое средство "троя" для ухода за кожей
JP4177738B2 (ja) 2003-09-18 2008-11-05 株式会社トキワ 塗布具
GB0411467D0 (en) * 2004-05-22 2004-06-23 Ball Burnishing Mach Tools A tapered applicator for treating and cleaning surfaces
WO2005112688A1 (en) * 2004-05-22 2005-12-01 Ball Burnishing Machine Tools Ltd. Multi-function surface treatment tool
US7201527B2 (en) * 2004-07-30 2007-04-10 Hct Limited Twist up pen type dispenser with brush applicator
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
FR2878157B1 (fr) * 2004-11-23 2007-03-02 Durlin France Sa Composition de vernis a base de solvant a base de solvant d'origine vegetale
JP4863437B2 (ja) * 2005-07-07 2012-01-25 有限会社日本健康科学研究センター 浴用フィルム製剤
US20070048355A1 (en) * 2005-08-26 2007-03-01 Daniel Perlman Non-irritating solvent-borne polymeric coatings for application to the skin
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
JP4836146B2 (ja) * 2006-10-24 2011-12-14 有限会社日本健康科学研究センター 皮膚上にフィルムを形成するフィルム製剤
US20080312196A1 (en) * 2007-06-15 2008-12-18 Cohen Carl J Topical wart removal composition
EP2143421A1 (en) * 2008-07-07 2010-01-13 Almirall Hermal GmbH Topical composition for the treatment of actinic keratosis
US9155842B2 (en) * 2008-07-09 2015-10-13 Sanofi-Aventis Deutschland Gmbh Medication delivery device and method of assembling a medication delivery device
JP6062186B2 (ja) * 2012-08-28 2017-01-18 古河電気工業株式会社 分岐鉄塔の架空線工事方法

Also Published As

Publication number Publication date
BR112012007550A8 (pt) 2018-06-12
KR20120094911A (ko) 2012-08-27
JP6317958B2 (ja) 2018-04-25
EP2485720B1 (en) 2018-08-22
JP2014129411A (ja) 2014-07-10
JP2013507367A (ja) 2013-03-04
EP2485720A4 (en) 2013-07-03
EP2485720A1 (en) 2012-08-15
CN107411990A (zh) 2017-12-01
HK1247133A1 (zh) 2018-09-21
RU2552470C2 (ru) 2015-06-10
IN2012DN02817A (pt) 2015-07-24
AU2010303696A1 (en) 2012-04-19
CA2775089C (en) 2015-12-08
WO2011044008A1 (en) 2011-04-14
US20110086109A1 (en) 2011-04-14
MX2012004144A (es) 2012-05-08
JP6200546B2 (ja) 2017-09-20
BR112012007550B1 (pt) 2020-01-14
AR078553A1 (es) 2011-11-16
AR109324A2 (es) 2018-11-21
JP5798561B2 (ja) 2015-10-21
AU2010303696B2 (en) 2013-05-23
JP2016000732A (ja) 2016-01-07
CN102573816A (zh) 2012-07-11
US8883767B2 (en) 2014-11-11
KR101791705B1 (ko) 2017-10-30
JP2016172748A (ja) 2016-09-29
TWI488628B (zh) 2015-06-21
RU2012118757A (ru) 2013-11-20
TW201125567A (en) 2011-08-01
CA2775089A1 (en) 2011-04-14
ES2688976T3 (es) 2018-11-07

Similar Documents

Publication Publication Date Title
BR112012007550A2 (pt) composição em gel, produtos de tratamento de verruga, e de calos/calosidade, método para tratar uma doença de pele, dispensador para administrar uma composição para tratar uma doença de pele em um indivíduo, e, método para aprimorar administração tópica de ácido salicílico a um indivíduo
US9283177B2 (en) Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
BRPI0910874B8 (pt) formulação tópica para uso no tratamento tópico de uma condição da pele que resulta da produção de espécies reativas de oxigênio e/ou para a promoção da cicatrização de ferida tópica na pele de um indivíduo e uso da referida formulação
BR112018011643A2 (pt) composto, composição cosmética ou farmacêutica, uso de um composto, e, método para tratamento e/ou cuidado não terapêutico e cosmético da pele, cabelo, unhas e/ou membranas mucosas.
BRPI0810848B8 (pt) água eletrolítica altamente estável com largura de meia linha de rmn reduzida
BR112014031394A2 (pt) composições e métodos para absorção transmucosa
US11890294B2 (en) Skin barrier composition
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
AR060836A1 (es) Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido
ES2378028B1 (es) Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
EA201170876A1 (ru) Применение способной к вспениванию композиции, по существу, не содержащей фармацевтически активные ингредиенты, для лечения кожи человека
Lubtikulthum et al. A comparative study on the effectiveness of herbal extracts vs 2.5% benzoyl peroxide in the treatment of mild to moderate acne vulgaris
BR112012008345A2 (pt) regime de dosagem para a administração de um anticorpo biespecífico de epcamxcd3
BR112014020271A8 (pt) Composição farmacêutica e métodos para diminuir a frequência de micção em paciente
BR112013006352A2 (pt) profármacos compostos profármacos de éster de [3-(1 -{1h-imidazol-4-il)etil)-2-metilfenil] metanol para tratar doenças e condições da pele, composição farmacêutica e artigo de fabricação
BR112017016087A2 (pt) formulações para coxim articular adiposo e métodos de uso das mesmas
BR112012027092A2 (pt) métodos e composiões para reduzir ou impedir a calcificação vascular durante a terapia de diálise peritoneal
Fleckman et al. Topical treatment of ichthyoses
US20190151394A1 (en) Prebiotic Acne Treatment
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
BRPI0417116A (pt) usos de uma quantidade eficaz de ondansetron e composição para tratamento tópico de uma inflamação
BR112015020261A2 (pt) composições farmacêuticas de dexmetilfenidato ou sais do mesmo de liberação modificada
BR112014027213A2 (pt) nova composição de alfentanil para o tratamento da dor aguda
Arthur et al. Effect of preservatives on reactivity of fluoride with dental enamel
Zegarska et al. Dermocosmetics in the management of acne vulgaris. Recommendations of the Polish Dermatological Society. Part II

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: MSD CONSUMER CARE, INC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: BAYER CONSUMER CARE HOLDINGS LLC (US)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: BAYER CONSUMER CARE AG (CH)

B25A Requested transfer of rights approved

Owner name: BAYER CONSUMER CARE AG (CH)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: BAYER CONSUMER CARE AG (CH)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/10/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.